分量流量储备对冠状动脉疾病临床决策的影响
Andrei Grib1, Marcel Abras1, Artiom Surev2
1Discipline of Cardiology, State University of Medicine and Pharmacy "Nicolae Testemitanu", MD 2004 Chisinau, Moldova.
Life (Basel, Switzerland)
|October 26, 2024
概括
分流储备 (FFR) 评估可以提高冠状动脉疾病的治疗准确性. 仅仅是视觉评估可能与功能意义不一致,突出FFR.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 医学成像分析 医学成像分析
背景情况:
- 分流储备 (FFR) 是评估冠状动脉损伤显著性的黄金标准.
- 尽管FFR的准确性已被证明,但其临床利用仍然有限.
研究的目的:
- 将FFR结果与视觉血管学评估进行比较,以指导冠状动脉疾病的治疗决策.
- 评估FFR对干预性心脏病治疗策略的影响.
主要方法:
- 对63名患有慢性或急性冠状动脉综合征的患者进行了回顾性研究,这些患者正在接受FFR评估.
- 三位经验丰富的干预心脏病学家对FFR结果失明,对105个模两可的冠状动脉病变进行了视觉重新评估.
- 治疗决定 (PCI或延期) 基于血管造影评估.
主要成果:
- 在57.1%的病变中,视觉评估导致了对PCI的一致同意,但在FFR中,15%的病变在功能上无意义.
- 在42.9%的病变中,PCI被推迟,但8.9%的病变因FFR具有功能意义,需要重新评估.
- 在视觉评估和FFR确定的功能意义之间存在显著的差异.
结论:
- 干预心脏病学家对冠状动脉病变的视觉评估显示出变化,并且不总是与FFR一致.
- 将FFR纳入常规临床决策可以提高冠状动脉疾病的治疗准确性.
- 使用FFR可能会改善患者在治疗冠状动脉疾病方面的治疗结果.
更多相关视频
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
949
06:39Ultrasound Based Assessment of Coronary Artery Flow and Coronary Flow Reserve Using the Pressure Overload Model in Mice
Published on: April 13, 2015
14.9K
相关概念视频
01:30Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
01:27Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
01:22Heart Failure VI: Adjunct Therapies
1
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
1
01:26Coronary Artery Disease IV: Medical Management
3
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
3
01:26Angina IV: Management
3
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
3